
Sign up to save your podcasts
Or


GLP-1 receptor agonists, like Ozempic, have been in the news for helping people transform their lives through weight loss. But they’ve also had an unexpected side effect – curbing alcohol consumption. Our expert explains the ongoing research and the future of using these medications as addiction treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Elizabeth Westfield, Greg Johnson, Maayan Voss de Bettancourt | AURN4.7
3232 ratings
GLP-1 receptor agonists, like Ozempic, have been in the news for helping people transform their lives through weight loss. But they’ve also had an unexpected side effect – curbing alcohol consumption. Our expert explains the ongoing research and the future of using these medications as addiction treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices

91,097 Listeners

43,637 Listeners

38,902 Listeners

27,212 Listeners

31 Listeners

59,196 Listeners

6,403 Listeners

30,236 Listeners

5,452 Listeners

41 Listeners

9,528 Listeners

50,293 Listeners

57,850 Listeners

2,088 Listeners

35 Listeners

10,262 Listeners

25 Listeners

4 Listeners

3 Listeners

7 Listeners

6 Listeners

0 Listeners

10,282 Listeners